Immunoglobulins, Intravenous - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.

13 Dec 2009 EBV-associated post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication following solid organ transplantation and hematopoietic stem cell transplantation (HSCT) using bone marrow or peripheral blood as stem cell sources, ... Read more...

Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009.

4 Nov 2009 Since 2003, the U.S. Department of Agriculture's Wildlife Services has coordinated a multistate oral rabies vaccination (ORV) program for wildlife in a 15-state zone extending from Maine to Alabama and in Texas. The program seeks to enhance local ... Read more...

Progress in pediatric vasculitis.

30 Aug 2009 PURPOSE OF REVIEW: To examine recent advances in the pathophysiology and therapy of pediatric vasculitis. RECENT FINDINGS: The past 2 years have been marked by significant progress in extending novel techniques to the investigation of the two most ... Read more...

Latest indexed articles for 'Immunoglobulins, Intravenous - Therapeutic use'

These are the very latest articles for this heading:

• Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy. 13 Dec 2009
• Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009. 4 Nov 2009
• Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. 18 Oct 2009
• Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis. 29 Sep 2009
• Progress in pediatric vasculitis. 30 Aug 2009
• A 3-day-old boy with acute flaccid paralysis. 30 Aug 2009
• Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. 30 Aug 2009
• Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children. 30 Aug 2009
• Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin. 13 Aug 2009
• Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. 13 Aug 2009
• Comèl-Netherton syndrome defined as primary immunodeficiency. 12 Aug 2009
• Low-affinity Fcgamma receptors, autoimmunity and infection. 11 Aug 2009
• Clinical characterization and successful treatment of 6 patients with Churg-Strauss syndrome-associated neuropathy. Aug 2009
• Recurrent pregnancy loss: a disease of inflammation and coagulation. 30 Jul 2009
• Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen. 30 Jul 2009
• Enterovirus 71: epidemiology, pathogenesis and management. 30 Jul 2009
• Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus. 30 Jul 2009
• A 6-year-old girl with unsteady gait. 30 Jul 2009
• The role of the histocompatibility laboratory in desensitization for transplantation. 30 Jul 2009
• Rational treatment options with AEDs and ketogenic diet in Landau-Kleffner syndrome: still waiting after all these years. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Immunoglobulins, Intravenous'

Definition: Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.

Registry Number: 0

Descriptor UI: D016756

Alternative terms: Immunoglobulins, Intravenous; Immune Globulin, Intravenous; Intravenous Immune Globulin; IVIG; Intravenous IG; Intravenous Immunoglobulins; IV Immunoglobulins; Immunoglobulins, IV; Antibodies, Intravenous; Intravenous Antibodies; Venoglobulin-I; Venoglobulin I; VenoglobulinI; Gamimune; Gamimmune; Gamimune N; Gamimmune N; Gammagard; Gammonativ; Globulin-N; Globulin N; GlobulinN; Intraglobin; Intraglobin F; Iveegam; Modified Immune Globulin (Anti-Echovirus Antibody); Sandoglobulin; Venimmune; Venoglobulin; Alphaglobin; Endobulin;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; classification; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacology; physiology; poisoning; radiation effects; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; pharmacokinetics; standards;

Pharmacological Action: Immunologic Factors;

Tree Number: D12.776.124.486.485.114.619.393.536; D12.776.124.486.485.114.632; D12.776.124.790.651.114.632; D12.776.377.715.548.114.632;

Online Note: use IMMUNOGLOBULINS, INTRAVENOUS (NM) to search GLOBULIN-N (NM) 1986-91, VENOGLOBULIN (NM) 1983-91, GAMMONATIV (NM) & INTRAGLOBIN (NM) 1982-91, and SANDOGLOBULIN (NM) & MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) (NM) 1981-91.

History Note: 92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV & INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN & MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) were NM 1981-91